Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Semaglutide

A Research Study to See How Semaglutide Helps People With Excess Weight and Type 2 Diabetes Lose Weight

Novo Nordisk · Phase 3 · Completed · Enrollment 512

NCT05649137

EudraCT 2022-002235-60

ArmPopulationDoseWeeksEstimandWeight change
Semaglutide 7.2 mgObesity + T2D7.2 mg72n/rn/r
Semaglutide 2.4 mgObesity + T2D2.4 mg72n/rn/r
PlaceboObesity + T2Dn/r72n/rn/r